-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Corvus Pharmaceuticals, Inc. quarterly Nonoperating Income (Expense) history and change rate from Q1 2024 to Q3 2025.
- Corvus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $415K.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)